NaYF_4:Yb/Er-碳纳米管功能纳米材料的制备、表征及其在肿瘤细胞的靶向检测和治疗中的应用

将叶酸分子(FA)和2,3-二巯基丁二酸(DMSA)修饰的稀土上转换发光纳米粒子NaYF4:Yb/Er通过酰胺键偶联在多壁碳纳米管(MWCNT)的表面,得到NaYF4:Yb/Er-MWCNT-FA功能化复合纳米材料,并通过透射电子显微镜(TEM)、X射线衍射(XRD)、紫外-可见吸收光谱(UV-vis)、荧光光谱(PL)和共聚焦激光扫描显微镜等手段表征了其形貌、结构、发光性能和靶向成像性能.共聚焦激光扫描显微镜结果表明,相对于正常的HLF细胞,所制备的复合材料能够靶向检测叶酸受体高表达的宫颈癌Hela细胞.此外,将阿霉素进一步通过ππ堆垛吸附在此复合材料后,该载药体系具有明显的抗肿瘤活性,能够实现对肿瘤细胞的一步检测和治疗.     

寡聚芴纳米粒子的制备、表征与细胞成像应用

利用Suzuki偶联反应合成了疏水性寡聚芴分子OF, 并对其在氯仿溶液中的紫外吸收和荧光光谱进行了表征, 表明其具有较大的摩尔吸光系数(1.08×10⁵ mol^-1·L·cm^-1)和高荧光量子产率(96%). OF分子分散到水中可形成纳米粒子, 动态光散射实验表明其粒径大小约为230 nm. 该纳米粒子在水相中仍保持了较大的摩尔吸光系数以及高的荧光量子产率. 我们利用MTT的方法对OF纳米粒子对人肺癌A549细胞的毒性进行了测试, 结果表明其具有低的细胞毒性, 因此可以用于细胞成像. 共聚焦激光扫描显微镜成像结果显示OF纳米粒子主要分布在细胞质中, 特别是在近核区域周围. 与溶酶体染料Lyso Tracker Red共定位结果表明OF纳米粒子主要存在于溶酶体中, 因此可以用于对溶酶体的特异性荧光成像.     

叶酸修饰的具有靶向功能的Mn_3O_4造影剂的制备及其在核磁共振成像中的应用

通过高温热解的方法制备出Mn3O4纳米粒子,再利用正硅酸四乙酯(TEOS)包硅改善其水溶性和稳定性,通过加入3-氨基丙基三乙氧基硅烷(APTES)使纳米粒子表面接入大量氨基,最后再连接增加磁性纳米粒子生物相容性的有机分子聚乙二醇(PEG)和靶向分子叶酸(FA),得到Mn3O4靶向造影剂.体外实验表明,该造影剂具有低的细胞毒性,并对宫颈癌细胞具有较好的磁共振增强成像效果以及主动靶向作用.     

富精氨酸多肽修饰的金纳米粒子跨膜传输

考察了富精氨酸多肽功能化的金纳米粒子作为载体对细胞外物质的跨膜传输行为. 通过生物素(Biotin)与亲和素(Streptavidin)的亲和反应将具有特定跨膜功能的富精氨酸RRRRRRRR(R₈)多肽分子连接到多肽CALNN修饰的金纳米粒子表面, 实现粒子的功能化. 以荧光素为模型化合物, 利用激光共聚焦显微镜观察了纳米粒子的输送过程. 实验结果表明, 富精氨酸多肽功能化的金纳米粒子可以作为一种低毒高效的跨膜输送载体.     

荧光介孔二氧化硅纳米粒子的合成及药物运输（英文）

合成了荧光介孔二氧化硅纳米粒子(MSNs-FITC),并研究了其在持续药物释放和生物示踪成像方面的应用。首先,采用一步法合成出MSNs-FITC,结合SEM、TEM、FT-IR、XRD和氮气吸附脱附等表征技术进行表征。其次,将抗癌药物阿霉素(DOX)负载到MSNs-FITC中。载药粒子的药物释放行为具有明显的pH依赖性,酸性环境加速释放速率。同时,体外细胞毒性测试表明MSNs-FITC具有良好的生物相容性。激光共聚焦扫描显微镜(CLSM)图像表明,MSNs-FITC可以进入细胞并具有剂量依赖性,流式细胞术分析(FCM)进一步证明了这一结果。     

NaGdF4:Eu荧光纳米粒子的合成及对肺癌细胞的生物标记

以柠檬酸钠为螯合剂,采用水热法合成了单分散的Eu3+掺杂NaGdF4纳米粒子,采用扫面电镜(SEM)、X射线粉末衍射(XRD)、荧光光谱对粒子进行了表征,结果表明,所合成的纳米粒子尺寸在60-80nm之间,粒度均匀,且具有良好的发光性能。基于其荧光性质,将其标记于肺癌细胞表面,利用激光扫描共聚焦显微镜对标记后的细胞进行荧光成像。在488 nm激发下,获得了红色荧光图像,48h后细胞仍然保持着很亮的荧光,显示出荧光纳米粒子很好的荧光稳定性,并采用MTT法检测肺癌细胞的存活率,对纳米粒子的毒性进行了初步评估。     

CD20靶向Cy7-Rituximab分子探针的制备及在小鼠活体荧光成像中的应用

以B淋巴细胞表面CD20抗原靶向的单克隆抗体Rituximab为载体, 通过共价键偶联荧光基团菁染料Cy7, 获得了新型荧光分子探针Cy7-Rituximab. 利用全光谱紫外-可见分光光度仪、SDS-聚丙烯酰胺凝胶电泳和基质辅助激光解析电离飞行时间质谱等对该探针结构进行表征, 并通过激光共聚焦显微镜观察了其在弥漫大B细胞淋巴瘤(DLBCL)细胞中的摄取情况. 选用BALB/C裸鼠为模型, 尾静脉注射 Cy7-Rituximab, 通过活体荧光成像系统观察了其在小鼠体内的分布情况. 研究结果表明, 修饰后的Cy7-Rituximab保持了原有抗体的免疫活性. 活体荧光成像结果表明, 在CD20高表达的脾脏部位监测到该分子探针的特异性浓集.     

基于碳点多功能纳米载药体系的制备及pH响应释药性能研究

采用一步微波法成功制备了表面带氨基的荧光纳米碳点CDots, 并通过酰胺化反应将靶向基团叶酸接枝到碳点表面, 成功获得中间产物CDots-FA. 在此基础上, 通过已合成四臂端酰肼基化合物2与抗肿瘤药物阿霉素(DOX)连接, 实现在碳点表面的阿霉素药物分子的化学键合, 最终获得多功能纳米载药体系DOX-CDots-FA. 利用原子力显微镜(AFM)、高分辨透射电镜(HR-TEM)和荧光光谱仪对荧光纳米碳点CDots的性能进行表征, 并通过核磁共振、紫外-可见吸收光谱对DOX-CDots-FA结构、接枝率进行了表征. 同时对纳米载药体系DOX-CDots-FA体外药物释放行为、细胞毒性及细胞摄取成像进行了系统的研究. 结果表明, DOX-CDots-FA具有良好的pH响应性. 叶酸靶向基团能加速DOX-CDots-FA被HeLa (FR+)细胞摄取, 并表现出更强的细胞毒性. 同时细胞摄入成像实验表明, 在叶酸靶向作用下, DOX-CDots-FA通过内吞作用进入HeLa细胞, 随后阿霉素被释放出来并进入细胞核区域, 抑制细胞的生长, 从而实现靶向治疗, 降低毒副作用.     

靶向性纳米金探针对宫颈癌细胞的激光扫描共聚焦散射成像

制备了粒径均一的纳米金颗粒, 再对其表面进行叶酸修饰, 制得具有靶向性的纳米金探针. 利用激光扫描共聚焦显微镜(LSCM), 对靶向性纳米金的细胞特异性散射成像进行研究. 实验结果表明, 人宫颈癌细胞(Hela)对纳米金-叶酸的摄取作用强于对纳米金的摄取, 但随着时间的延长, 两者的差别逐渐减小. 表明在适当的时间内纳米金-叶酸探针对宫颈癌细胞具有良好的靶向性.     

点击功能化的叶酸受体靶向荧光纳米探针用于肿瘤细胞成像

采用点击化学偶联法对荧光二氧化硅纳米粒子表面进行叶酸功能化修饰,构建了一种叶酸受体靶向的荧光纳米探针,并成功用于肿瘤细胞的成像研究.首先通过St?ber法制备包裹钌联吡啶的荧光二氧化硅纳米粒子(RSiNPs),然后利用叠氮化硅烷偶联剂(Az-PTES)的水解反应在其表面引入叠氮基团,最后通过点击化学反应将炔丙基叶酸衍生物偶联到粒子表面.利用红外光谱对其偶联前后的叠氮基特征峰(2105 cm-1)进行表征,证实了叶酸功能化的荧光纳米探针(RSiNPs-Folate)已被成功制备.在生理pH条件下,以458 nm为激发波长,RSiNPs-Folate在601 nm处发射较强的红色荧光,且光稳定性较好.细胞成像结果表明,这种叶酸受体靶向的荧光纳米探针能够有效地标记叶酸受体呈阳性的人宫颈癌细胞(HeLa),而叶酸受体呈阴性的人肺癌细胞(A549)未观察到明显的荧光.叶酸竞争性结合实验证明了这种叶酸受体介导的肿瘤细胞成像机制.此探针能够实现混合细胞体系中HeLa细胞的选择性识别与荧光成像.与酰胺化反应偶联叶酸相比,这种点击功能化的纳米探针的合成方法简单、反应条件温和、产率高,可用于不同肿瘤细胞的荧光标记与成像.     

Doxorubicin-containing microparticles comprising cinnamoyl gelatin-folic acid conjugate,cinnamoyl Pluronic F127, and cinnamoyl poly(β-cyclodextrin)

Microparticles comprising of cinnamoyl gelatin (type A) (CA-GelA), cinnamoyl gelatin (type B) (CA-GelB), cinnamoyl Pluronic F127 (CA-Plu), and cinnamoyl poly(β-cyclodextrin) (CA-P(βCD)) were prepared as a carrier for doxorubicin (DOX). Folic acid (FA) was covalently attached to CA-GelA as a targeting molecule for cancer cells. The covalent attachment of FA was confirmed by ¹H-NMR spectroscopy. On the TEM micrographs, the microparticles were almost circular and they were a few hundreds of nanometers in diameter. The release at pH7.4 of DOX from microparticle/DOX suspension was more extensive when the FA content of microparticles was lower and the temperature of release medium was higher. According to the flow cytometric analysis, the lager amount of FA seemed to make the interaction of the microparticle and KB cell more favorable. On confocal laser fluorescence micrograph, the cell treated with microparticle bearing FA showed relatively strong DOX fluorescence, indicating the strong interaction of the microparticle and KB cells.     

Cancer Cell Imaging Using in Situ Generated Gold Nanoclusters

In situ generated fluorescent gold nanoclusters (Au‐NCs) are used for bio‐imaging of three human cancer cells, namely, lung (A549), breast (MCF7), and colon (HCT116), by confocal microscopy. The amount of Au‐NCs in non‐cancer cells (WI38 and MCF10A) is 20–40 times less than those in the corresponding cancer cells. The presence of a larger amount of glutathione (GSH) capped Au‐NCs in the cancer cell is ascribed to a higher glutathione level in cancer cells. The Au‐NCs exhibit fluorescence maxima at 490–530 nm inside the cancer cells. The fluorescence maxima and matrix‐assisted laser desorption ionization (MALDI) mass spectrometry suggest that the fluorescent Au‐NCs consist of GSH capped clusters with a core structure (Au_8‐13). Time‐resolved confocal microscopy indicates a nanosecond (1–3 ns) lifetime of the Au‐NCs inside the cells. This rules out the formation of aggregated Au–thiolate complexes, which typically exhibit microsecond (≈1000 ns) lifetimes. Fluorescence correlation spectroscopy (FCS) in live cells indicates that the size of the Au‐NCs is ≈1–2 nm. For in situ generation, we used a conjugate consisting of a room‐temperature ionic liquid (RTIL, [pmim][Br]) and HAuCl₄. Cytotoxicity studies indicate that the conjugate, [pmim][AuCl₄], is non‐toxic for both cancer and non‐cancer cells.     

Design and Synthesis of ZnII‐Coordination Polymers Anchored with NSAIDs: Metallovesicle Formation and Multi‐drug Delivery

A series of coordination polymers synthesized from a bis‐pyridyl linker, namely 4,4′‐azopyridine ( L ), selected non‐steroidal‐anti‐inflammatory drugs (NSAIDs), namely diclofenac ( Dic ), ibuprofen ( Ibu ), flurbiprofen ( Flu ), mefenamic acid ( Mefe ), and naproxen ( Nap ), and Zn(NO₃)₂ were characterized by single crystal X‐ray diffraction. One of the coordination polymers, namely CP3 derived from Flu , was able to form metallovesicles in DMSO, DMSO/H₂O and DMSO/DMEM (biological media) as revealed by TEM, AFM and DLS. Metallovesicle formation by CP3 was further supported by loading a fluorescent dye, namely calcein, as well as an anti‐cancer drug, doxorubicin hydrochloride ( DOX ), as revealed by UV‐vis and emission spectra, and fluorescence microscopy. DOX ‐loaded metallovesicles of CP3 ( DOX@CP3‐vesicle ) could be delivered in vitro to a highly aggressive human breast cancer cell line, namely MDA‐MB‐231, as revealed by MTT and cell migration assays, and also cell imaging performed under laser scanning confocal microscope (LSCM). Thus, a proof of concept for developing a multi‐drug delivery system derived from a metallovesicle for delivering an anti‐cancer drug to cancer cells is demonstrated for the first time.     

Covalent Modification of Reduced Graphene Oxide by Means of Diazonium Chemistry and Use as a Drug‐Delivery System

Under acidic conditions, reduced graphene oxide (rGO) was functionalized with p‐aminobenzoic acid, which formed the diazonium ions through the diazotization with a wet‐chemical method. Surfactants or stabilizers were not applied during the diazotization. After the functionalized rGO was treated through mild sonication in aqueous solution, these functionalized rGO sheets were less than two layers, which was determined by atomic force microscopy (AFM) imaging. The water solubility of functionalized rGO after the introduction of polyethyleneimine (PEI) was improved significantly; it was followed by covalent binding of folic acid (FA) molecules to the functionalized rGO to allow us to specifically target CBRH7919 cancer cells by using FA as a receptor. The loading and release behaviors of elsinochrome A (EA) and doxorubicin (DOX) on the functionalized rGO sheets were investigated. The EA loading ratio onto rGO‐C₆H₄‐CO‐NH‐PEI‐NH‐CO‐FA (abbreviated rGO‐PEI‐FA, the weight ratio of drug loaded onto rGO‐PEI‐FA) was approximately 45.56 %, and that of DOX was approximately 28.62 %. It was interesting that the drug release from rGO‐PEI‐FA was pH‐ and salt‐dependent. The results of cytotoxicity (3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT) and flow cytometry (FCM) assays, as well as cell morphology observations) clearly showed that the concentration of rGO‐PEI‐FA as the drug‐delivery composite should be less than 12.5 mg L ^?1. The conjugation of DOX and rGO‐PEI‐FA can enhance the cancer‐cell apoptosis effectively and can also push the cancer cells to the vulnerable G2 phase of the cell cycle, which is most sensitive and susceptible to damage by drugs or radiation.     

pH‐sensitive carbon quantum dots−doxorubicin nanoparticles for tumor cellular targeted drug delivery

A kind of pH‐responsive carbon quantum dots?doxorubicin nanoparticles drug delivery platform (D‐Biotin/DOX‐loaded mPEG‐OAL/N‐CQDs) was designed and synthesized. The system consists of fluorescent carbon dots as cross‐linkers, and D‐Biotin worked as targeting groups, which made the system have a pH correspondence, doxorubicin hydrochloride (DOX) as the target drug, oxidized sodium alginate (OAL) as carrier materials. Ultraviolet (UV)‐Vis spectrum showed that the drug‐loading rate of DOX is 10.5%, and the drug release in vitro suggested that the system had a pH response and tumor cellular targeted, the drug release rate is 65.6% at the value of pH is 5.0, which is much higher than that at the value of pH is 7.4. The cytotoxicity test and laser confocal fluorescence imaging showed that the synthesized drug delivery system has high cytotoxicity to cancer cells, and the drug‐loaded nanoparticles could enter the cells through endocytosis.     

叶酸修饰星型端氨基PEG-PLGA纳米胶束的制备及肿瘤细胞靶向作用

合成了星型多臂端氨基聚乙二醇(PEG)/聚乳酸-羟基乙酸(PLGA)两亲性嵌段共聚物(4s-PLGA-PEG-NH₂), 并通过核磁共振和凝胶渗滤色谱法对其结构进行表征; 采用溶剂挥发法制备阿霉素载药纳米胶束, 利用EDC缩合法与叶酸偶联, 得到叶酸修饰的星型端氨基PEG-PLGA纳米胶束; 采用动态光散射、 紫外光谱及透射电镜等手段对纳米胶束进行了表征; 对载药纳米胶束在HeLa细胞中的摄取及细胞毒性进行了初步评价. 结果表明, 经叶酸修饰的星型多臂端氨基PEG-PLGA载药纳米胶束可有效提高HeLa细胞的摄取率以及对HeLa细胞的杀伤率, 表明其可作为一类新型的靶向抗肿瘤药物递送载体.     

Theranostic hyaluronic acid prodrug micelles with aggregation-induced emission characteristics for targeted drug delivery

Theranostic hyaluronic acid (HA) prodrug micelles with pH-responsive drug release and aggregation-induced emission (AIE) properties were prepared by chemical graft of biomimetic phosphorylcholine (PC), anticancer drug doxorubicin (DOX) and AIE fluorogen tetraphenylene (TPE) to the HA backbone. DOX was conjugated to the HA backbone by a hydrazone bond which can be hydrolyzed under acidic environment and result in pH-triggered smart release of DOX. The TPE units with typical AIE characteristics were applied for real time drug tracking in cancer cells. The HA-based prodrugs could self-assemble into micelles in aqueous solution as confirmed by the dynamic light scattering (DLS) and transmission electron microscopy (TEM). The intracellular distribution of HA prodrug micelles could be clearly observed by fluorescence microscopy based on the strong fluorescence of TPE. Moreover, after treated with the micelles, stronger fluorescence of TPE in CD44 overexpressed MDA-MB-231 cancer cells was observed, compared to the CD44 negative cell line, NIH3T3 cells, suggesting efficient cell uptake of HA prodrug micelles by receptor-mediated endocytosis. The cell viability results indicated that the prodrug micelles could inhibit the proliferation of the cancer cells effectively. Such pH-triggered theranostic drug delivery system with AIE features can provide a new platform for targeted and image-guided cancer therapy.     

Folic acid modified electrospun poly(vinyl alcohol)/polyethyleneimine nanofibers for cancer cell capture applications

Capture and detection of metastatic cancer cells are crucial for diagnosis and treatment of malignant neoplasm. Here, we report the use of folic acid (FA) modified electrospun poly(vinyl alcohol) (PVA)/polyethyleneimine (PEI) nanofibers for cancer cell capture applications. Electrospun PVA/PEI nanofibers crosslinked by glutaraldehyde vapor were modified with FA via a poly(ethylene glycol) (PEG) spacer, followed by acetylation of the fiber surface PEI amines. The formed FA-modified nanofibers were well characterized. The morphology of the electrospun PVA/PEI nanofibers is smooth and uniform despite the surface modification. In addition, the FA-modified nanofibers display good hemocompatibility as confirmed by hemolysis assay. Importantly, the developed FA-modified nanofibers are able to specifically capture cancer cells overexpressing FA receptors, which were validated by quantitative cell counting assay and qualitative confocal microscopy analysis. The developed FA-modified PVA/PEI nanofibers may be used for capturing circulating tumor cells for cancer diagnosis applications.     

Minimalism in fabrication of self-organized nanogels holding both anti-cancer drug and targeting moiety

Recent researches to develop nano-carrier systems in anti-cancer drug delivery have focused on more complicated design to improve therapeutic efficacy and to reduce side effects. Although such efforts have great impact to biomedical science and engineering, the complexity has been a huddle because of clinical and economic problems. In order to overcome the problems, a simplest strategy to fabricate nano-carriers to deliver doxorubicin (DOX) was proposed in the present study. Two significant subjects (i) formation of nanoparticles loading and releasing DOX and (ii) binding specificity of them to cells, were examined. Folic acid (FA) was directly coupled with pullulan (Pul) backbone by ester linkage (FA/Pul conjugate) and the degree of substitution (DS) was varied, which were confirmed by 1H NMR and UV spectrophotometry. Light scattering results revealed that the nanogels possessed two major size distributions around 70 and 270 nm in an aqueous solution. Their critical aggregation concentrations (CACs) were less than 10 microg/mL, which are lower than general critical micelle concentrations (CMCs) of low-molecular-weight surfactants. Transmission electron microscopy (TEM) images showed well-dispersed nanogel morphology in a dried state. Depending on the DS, the nanogels showed different DOX-loading and releasing profiles. The DOX release rate from FA8/Pul (with the highest DS) for 24h was slower than that from FA4/or FA6/Pul, indicating that the FA worked as a hydrophobic moiety for drug holding. Cellular uptake of the nanogels (KB cells) was also monitored by confocal microscopy. All nanogels were internalized regardless of the DS of FA. Based on the results, the objectives of this study, to suggest a new method overcoming the complications in the drug carrier design, were successfully verified.     

Hyperbranched copolymer micelles as delivery vehicles of doxorubicin in breast cancer cells

Four types of drug nanoparticles (NPs) based on amphiphilic hyperbranched block copolymers were developed for the delivery of the chemotherapeutic doxorubicin (DOX) to breast cancer cells. These carriers have their hydrophobic interior layer composed of the hyperbranched aliphatic polyester, Boltorn^® H30 or Boltorn^® H40, that are polymers of poly 2,2‐bis (methylol) propionic acid (bis‐MPA), while the outer hydrophilic shell was composed of about 5 poly(ethylene glycol) (PEG) segments of 5 or 10 kDa molecular weight. A chemotherapeutic drug DOX, was further encapsulated in the interior of these polymer micelles and was shown to exhibit a controlled release profile. Dynamic light scattering and transmission electron microscopy analysis confirmed that the NPs were uniformly sized with a mean hydrodynamic diameter around 110 nm. DOX‐loaded H30‐PEG10k NPs exhibited controlled release over longer periods of time and greater cytotoxicity compared with the other materials developed against our tested breast cancer cell lines. Additionally, flow cytometry and confocal scanning laser microscopy studies indicated that the cancer cells could internalize the DOX‐loaded H30‐PEG10k NPs, which contributed to the sustained drug release, and induced more apoptosis than free DOX did. These findings indicate that the H30‐PEG10k NPs may offer a very promising approach for delivering drugs to cancer cells. © 2011 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem, 2012